Background and Purpose-About 50% to 80% of stroke survivors present with somatosensory deficits. Somatosensory deficits because of an ischemic stroke are determined by the infarct location. However, a detailed understanding of the long-term effect of lesions on somatosensory performance is lacking. Methods-This prospective observational study enrolled 101 ischemic stroke patients. For voxel-based lesion-symptom mapping, magnetic resonance imaging fluid-attenuated inversion recovery imaging infarct lesions were segmented within 5 days after stroke. Standardized tests such as the National Institutes of Health Stroke Scale and the Rivermead Assessment of Somatosensory Performance were performed during acute stage, after 3 and 12 months. This included bilateral testing for multiple tactile and proprioceptive somatosensory modalities (pressure, light touch, sharp-dull discrimination, temperature discrimination, sensory extinction, 2-point discrimination, and joint position and movement sense). We further study the association of acute somatosensory deficit with functional outcome 12 months after stroke assessed by the modified Rankin Scale using univariate and multiple linear regression analysis also including acute motor deficit assessed by the arm research action test. Results-Sixty patients (59.4%) showed impairment in at least one somatosensory modality. Light touch was most frequently affected (38.7%), whereas temperature was least frequently affected (21.8%). After 3 months, significant recovery was observed in all somatosensory modalities, with only minor additional improvements after 12 months. Voxel-based lesionsymptom mapping revealed significant associations of lesions in the primary and secondary somatosensory and insular cortex with somatosensory deficits. Acute somatosensory deficit was associated with functional outcome at 12 months. However, including the acute motor deficit, somatosensory deficit was no longer an independent predictor of functional outcome. Conclusions-Our study confirms that somatosensory deficits are frequent in acute ischemic stroke but largely recover over time. Infarct lesions in the primary and secondary somatosensory cortex and insula show a robust association with somatosensory impairment. Long-term disability is influenced by somatosensory deficits but driven by motor symptoms.
S omatosensory deficits are a frequent symptom of stroke, reported to be present in 25% and 85% of patients in 2 previous case series. [1] [2] [3] Somatosensation consists of different modalities. Exteroception includes superficial tactile stimulus perception via mechanoreceptors, thermoreceptors, and nociceptors, while proprioception includes deep sensory inputs from muscles and joints. 4 Patients often complain about somatosensory disturbances in clinical practice. 5 Despite this fact, true prevalence of somatosensory impairment in stroke patients can be underestimated in clinical practice, 3, 6, 7 because motor symptoms usually raise greater awareness in the therapists while accompanying somatosensory deficits may be overlooked especially in the acute stage. 8 There is some evidence from small cohorts that somatosensory disturbances recover over time, at least partially. [9] [10] [11] [12] Somatosensory impairments because of an ischemic stroke are critically determined by the location of the infarct lesion in the brain. [13] [14] [15] Imaging studies proved that lesions in the thalamus, dorsal internal capsule, corona radiata, pons, and cortical areas were associated with somatosensory deficits. [16] [17] [18] [19] From voxel-based lesion-behavior mapping, it is known that light touch impairment is associated with lesions in the secondary somatosensory and insular cortex.
14 A cross-sectional cohort study found 2 core regions, the sensory component of the superior thalamic radiation and the secondary somatosensory cortex, which contribute to somatosensory disturbances with respect to the modalities: light touch, pressure, pinprick pain, and proprioception.
in acute stroke and how they recover over time. There is also little data on the association of infarct lesion location and the presence and course of somatosensory deficits. We studied presence and time course of somatosensory symptoms from the acute to the chronic stage after ischemic stroke and their association with infarct lesion location.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Patients
This prospective observational patient study enrolled consecutive acute stroke patients with first-ever stroke between May 2014 and February 2017. The study protocol was approved by the local ethics committee Ethikkommission der Ärztekammer Hamburg. Patients were considered for participation according to the following inclusion criteria: age over 18 years; first-ever ischemic stroke; first full clinical assessment possible within 4 days after stroke onset; acute ischemic brain lesion observed in magnetic resonance imaging or computed tomography scan; written informed consent. Exclusion criteria were transitory ischemic attack, acute intracranial hemorrhage, spinal infarction, severe aphasia, severe cognitive deficit or dementia, severe psychiatric condition, disturbance of consciousness, severe peripheral polyneuropathy, severe chronic pain syndrome, active cancer, any systemic condition with severe affection of the central nervous system, participation in any clinical trial, any previous stroke (ischemic or hemorrhagic), or head trauma.
Prospective Observation
The study comprised 3-time points of assessment: the acute stage within the first 5 days after stroke onset, the chronic stage at 3 months after stroke onset, and the late chronic stage at 12 months after stroke onset. Imaging data were acquired during the acute phase. Behavioral data were assessed at all time points. At the acute stage (first-time point of assessment), an magnetic resonance imaging scan of the brain was obtained from each patient.
In all patients, somatosensory and motor deficits were assessed using several standardized scales. At all time points, the neurological deficit was assessed by the National Institutes of Health Stroke Scale (NIHSS) and the pure motor deficit by the arm research action test (ARAT); the functional outcome defined as modified Rankin Scale after 3 and 12 months.
For the assessment of the somatosensory ability, the Rivermead Assessment of Somatosensory Performance (RASP) was used 20 as a validated test battery established for the use in stroke studies. 4, 11, [21] [22] [23] This standardized protocol comprises reliable testing of the following somatosensory abilities covering tactile and proprioceptive modalities: surface pressure touch, hot-cold temperature discrimination, sharp-dull discrimination, bilateral touch discrimination (sensory extinction), 2-point discrimination, joint movement, and movement direction discrimination. According to the protocol, these somatosensory modalities were assessed at 10 test regions (5 left, 5 right): on the face (cheek), on the shoulder, on the palm of the hand, on the leg, and on the dorsum of the foot. In addition to the RASP test, we assessed light touch perception using a cotton swab at the same test regions.
Statistical and Imaging Analysis
For comparison of longitudinal somatosensory deficits across time points, results of somatosensory subtests of the RASP scores were dichotomized into intact or impaired. To this end, cutoff thresholds for each somatosensory subitem based on the original RASP reliability and validity study were taken for binarization of each subitem. 20 A linear mixed-effects model regression including factors subject and time point was calculated to analyze longitudinal behavioral performance. We used univariate and multivariate linear regression to study the association of initial somatosensory deficit (defined as acute RASP score) and motor deficit (acute ARAT score) with functional outcome (modified Rankin Scale) after 12 months.
Magnetic resonance images of the brain were obtained with 1.5T scanners. Either 3-dimensional or 2-dimensional fluid-attenuated inversion recovery imaging (FLAIR) data and diffusion-weighted images were acquired at days 3 to 7 after stroke onset. As described previously, individual stroke lesions of the patients were segmented on fluid-attenuated inversion recovery imaging sequences 13,24 using in-house software. 25 In 2 cases, only computed tomography scans were available. In these 2 cases, manual delineation of the lesion was done using FSL software package 5.1 (http://www.fmrib.ox.ac. uk/fsl). Stroke lesions were binarized and registered to standard Montreal Neurological Institute space. Individual normalized stroke lesions were entered into a voxel-based lesion-symptom mapping analysis using the nonparametric mapping toolbox from the MRICron software Version May 2016. 26 To increase the statistical power of identifying a lesion pattern with a significant contribution to somatosensory deficits independent of the lesioned hemisphere, all lesion maps were flipped onto the right hemisphere, as reported before. 13, 24 First, a lesion overlap was calculated to create a color-coded overlay map of injured voxels across all patients to provide an overview of all lesioned brain areas. Second, the statistical contribution of lesion location to somatosensory deficit was tested using voxel-based lesion-symptom mapping. Therefore, in each voxel, a group comparison between patients having a lesion in this voxel and patients having no lesion in this voxel was estimated as Brunner-Munzel rank order using the somatosensory scores of the RASP scores. Multiple comparisons is a common problem in multivariate lesion-symptom mapping analyses. To reduce false positive alerts, a large sample size of >100 patients and a permutation-derived multiple comparison correction applying a family-wise error rate of 0.05 as a rather conservative threshold was used for this study, as suggested in methodological literature.
27,28

Results
A total number of 1382 consecutive patients at the stroke unit were screened for eligibility of participation in the study. Of those, 101 (7.3%) patients met inclusion criteria ( Figure 1 ).
Of 101 patients enrolled and studied at baseline, 66 (65%) completed the follow-up examination after 3 months and 55 (54%) completed the 12 months follow-up. Of the lost followups, one patient died after the initial measurement, the rest had various reasons for declining further participation (eg, were under treatment in distant rehabilitation center, were not able to be transferred to the hospital, withdrew consent to participate, or were not reachable via telephone nor post). In total, 46 patients completed the entire study with all 3-time point measurements, see Figure 1 .
Median age of patients included was 64 (range 29-88) years, 32 (32%) were female. Sixty-five patients had righthemispheric stroke lesions, 36 had left-hemispheric stroke lesions. Ninety-five patients were right-handed, 6 left-handed. In 23 patients, acute reperfusion treatment with systemic thrombolysis had been performed.
Baseline
The median NIHSS value at baseline was 2, ranging from 0 to 21; interquartile range from 1 to 4. In the sensory subscale of the NIHSS, the median value was 1, ranging from 0 to 2; interquartile range from 0 to 1. In 53 patients (52.5%), sensory disturbances in the NIHSS somatosensory subitem were recorded.
For the RASP sensory assessment reflecting both sides of the body, a maximum total score of 386 points was achievable. Twenty-one patients (21%) had the full score of 386 points and thus showed no sensory disturbances at all. The mean total score was 355.2±49.6 points (mean±SD).
Considering only the test results from the most affected body side-contralateral to the infarcted brain hemisphere, ipsilateral in cerebellar/medullary stroke-the maximum achievable score was 193 points. Twenty-two patients (22%) presented the full score in the body areas potentially affected by their stroke lesions. The mean score across all patients on the affected body side was 164.0±48.2 (mean±SD) and on the nonaffected side 191.2±4.3, see Table 1 . In all 7 subitems, paired t tests between affected and nonaffected body side revealed significant differences in test results favoring the nonaffected side, all P values <0.001.
According to the dichotomized results of the RASP, 60 out of 101 patients (59.4 %) had an impairment in at least one somatosensory subitem. Of those, 20 had impaired performance in one subitem, while 40 had an impairment in >1 subitem. See Figure 2A for a distribution of the number of impaired subitems.
With regard to the different somatosensory modalities, 28 patients (27.7%) exhibited impaired pressure perception, 39 Figure 2B ).
Longitudinal Data
For statistical analysis of the longitudinal course, only the 46 patients who completed all 3-time points were considered. NIHSS significantly decreased from T1 to T2 and T3 (P<0.001). The RASP sum score significantly increased from T1 to T2 and T3 (P<0.001), see Table 2 . Mixed-model analysis including factors subject and time point showed a significant fixed effect for time point, for both NIHSS and RASP sum score and all 7 subitems ( Figure 3A and 3B). According to the thresholded values of RASP subscores, the proportion of patients with sensory deficits in at least one subitem significantly decreases from 56.5 % to 43.5% and 39.1% over the time. The longitudinal course of the scores of all 7 somatosensory modalities captured in RASP also showed a significant increase over time from 19.6% to 34.8 % at baseline to 6.5% to 21.7 % after 12 months (Table 2 ; Figure 3C ). 
Association of Somatosensory and Motor Deficits With Functional Outcome
Lesion-Symptom Mapping
The distribution of stroke lesions showed a predominance in the middle cerebral artery territory with deep middle cerebral artery territory and insula being most frequently affected, but there were also lesions in the brain stem ( Figure 4A ). In the voxel-based lesion-symptom mapping analysis, the sensory subscale of the NIHSS at baseline showed significant associations with lesions in the primary somatosensory cortex (S1), only. At T2 and T3, no significant associations were found after applying the prespecified level of correction for multiple comparisons. For the RASP sum score, significant associations between lower score values and lesioned brain tissue were found in the primary and secondary somatosensory cortex (S1, S2), the dorsal insular cortex, and frontoparietal subcortical areas. Interestingly, the subcortical course of the pyramidal tract did not show a significant association with the RASP sum score. At T2, only S1 and S2 showed significant involvement with impaired somatosensation. At T3, now statistical significance was found between lesion sites and somatosensory performance ( Figure 4B ; left-hand side).
Patterns of brain voxels associated with lower values in the 7 subitems of the RASP were slightly different for the different somatosensory modalities, but S1 and S2 showed up for virtually all subscores. Associations for 2-point discrimination were strictly limited to S1, its subcortical connections and a small area of S2. For proprioception, sensory extinction, pressure, and light touch, frontal-subcortical areas close to the frontal insular cortex and the external capsule were significantly associated. In addition, proprioception and sharp-dull discrimination showed associations with a subcortical area in the parietal associative cortex. Proprioception and sensory extinction had also associations with the putamen (Figure 4B ; right-hand side).
Discussion
In our population of patients with acute ischemic stroke, almost 60% showed somatosensory impairment in at least one subitem in the acute stage. This is largely in line with previous studies examining somatosensory disturbances in the acute stroke which reported somatosensory deficits in 28% to 85% of patients in different cohorts. 3, 7, 10, [29] [30] [31] The extent of somatosensory deficits ranged from deficits in only one specific subtest to impairment in all tested modalities. The For NIHSS and its subscale, the median and interquartile range (in brackets) and for the RASP score and its subitems, mean values±SD (in brackets) are given in the first columns. RASP values reflect results from the affected side. The last columns indicate the proportion of patients that have an impairment in the given the somatosensory subitem according to the impairment thresholds for the RASP test. NIHSS indicates National Institutes of Health Stroke Scale; RASP, Rivermead Assessment of Somatosensory Performance; T1, acute stage within 5 days after stroke onset; T2, after 3 months; and T3, after 12 months.
*Proportion of patients with any deficit in the sensory subscale of the NIHSS. †Gives the proportion of patient that have deficit in at least one or more subitems. 
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most frequently affected somatosensory modalities were light touch, sensory extinction, and 2-point discrimination, whereas temperature and sharp-dull discrimination were less frequently affected. From a clinical perspective it seems noteworthy that using a dedicated test (ie, the RASP), somatosensory impairment was detected in larger number of patients than in the somatosensory subscale of the NIHSS, with the latter being the most widely used scale for standardized assessment of stroke symptoms (59.4% versus 52.5%). Relying on global assessment scales like the NIHSS alone may result in overlooking somatosensory deficits in a relevant number of patients.
Altogether, somatosensory deficits improved during recovery from stroke in our sample. The proportion of patients with any impairment in somatosensory performance decreased from 57% in the acute stage to 39% after 12 months.
About the different somatosensory multimodal inputs, largest recovery was observed in light touch sense and proprioception, while temperature discrimination showed less improvement over time. An explanation might be that impaired temperature sense often occurs in brain stem lesions whereas light touch and proprioception rather occur in cortical stroke lesions. Thus, differential recovery rates may be explained with different neuroplastic recruitment in cortical areas compared with the brain stem. 32 Acute somatosensory symptoms were associated with functional outcome 12 months after stroke but this association was no longer present, when acute motor symptoms were added to the model. This indicates that functional outcome after stroke assessed by a rough measure as the modified Rankin Scale focusing on disability, strongly depends on the absence or presence of motor symptoms. Thus, for predicting functional independence or disability, detailed assessment of acute somatosensory deficits may not be necessary. However, disability is not the only factor with an impact on patients' health status and quality of life, but problems in other domains are also known to play an important role. 33 The impact of somatosensory deficits on patient-reported outcomes warrants further study. Furthermore, this observational study did not focus on the impact of rehabilitation on the pattern of recovery. From the patient sample with available follow-up data, it is known that 55% of patients received in-patient residential rehabilitative therapy with a large range in duration from 2 days to 25 weeks whereas 43% received out-patient ambulatory therapies or no therapy after discharge from acute hospital. To which extent the particular therapeutic intervention influenced the recovery in the follow-up assessments remains unclear.
Voxel-based lesion symptom mapping analysis revealed that stroke lesions in the primary and secondary somatosensory cortex and in the dorsal insular cortex were associated with somatosensory symptoms. These results are plausible, as the mentioned brain regions are well known to be involved in sensory processing. In addition, frontal-subcortical areas showed significant involvement in somatosensory impairment, affirming recent findings in similar voxel-based lesion symptom mapping analyses. 13, 14, 19 In general, the different sensory deficits measured with the RASP were associated with more widespread locations in the hemisphere compared with the associations with the sensory subscale of the NIHSS, which were confined to S1. This is plausible, because the NIHSS sensory item assesses tactile perception only, whereas the RASP tests include both simple perceptions (pressure and light touch) and more integrative tasks (2-point discrimination, sensory extinction, joint position, and movement sense). This may also explain the slightly different patterns of brain regions associated with impairment in the 7 different RASP subitems. Interestingly, the thalamus did not show up in any of our analyses. This may be because of statistical effects since only few patients had lesions in the thalamus in our sample.
No clear association of stroke lesion and persistent sensory deficits after 12 months was seen in our analyses. This may indicate that different factors beyond infarct lesion location may play a crucial role for recovery or persistence of somatosensory symptoms. On top of that, the number of patients with persistent deficits might have been too small to statistically grasp an existing association between acute imaging and chronic behavioral outcome.
Our study protocol comprised highly detailed somatosensory assessment in a large unselected consecutive stroke population with prospective evaluation over a follow-up period of 12 months. Thus, it enables a sound estimation of the distribution and recovery of sensory impairment. However, because of the heterogeneity of brain lesions from stroke disease, our sample size or the methodology might still restrict our ability to discover all associations of lesion sites with somatosensory symptoms, for example, brain stem infarctions are typically underestimated using voxel-based lesion symptom mapping. In addition, during the longitudinal study, a large rate of dropouts reduced the number of patients with a complete dataset to <50% of the initial sample size.
To summarize, we present prospective data on somatosensory deficits in ischemic stroke with highly detailed behavioral assessment and lesion imaging in a large sample size. About 60% of the patients suffered from any kind of somatosensory deficit. Somatosensory impairment significantly improved over time and improvement was largely seen within the first 3 months after stroke onset. Stroke lesions in the primary and secondary somatosensory cortex and in the insula showed a strong association with somatosensory impairment with additional different patterns for the different somatosensory modalities. Finally, while acute somatosensory deficits are no predictor of functional outcome, their impact on other health domains warrants further research.
